Peters R K, Kjos S L, Xiang A, Buchanan T A
Department of Preventive Medicine, School of Medicine, University of Southern California, Los Angeles, USA.
Lancet. 1996 Jan 27;347(8996):227-30. doi: 10.1016/s0140-6736(96)90405-5.
Pregnancy is associated with marked insulin resistance that seems to have little, if any, impact on the long-term risk of non-insulin-dependent diabetes mellitus (NIDDM) in the general population. The aim of this study was to test whether pregnancy would alter the risk of NIDDM among women with a high prevalence of pancreatic beta-cell dysfunction, as indicated by a history of gestational diabetes mellitus.
The cohort consisted of 666 Latino women with gestational diabetes attending a high-risk family planning clinic. They were followed up for up to 7.5 years, during which time they were weighed and underwent an oral glucose-tolerance test annually. The effect of an additional pregnancy, and of other risk factors for diabetes, was examined.
87 (13%) of the women completed an additional pregnancy. 80 of those women did not have NIDDM immediately after the additional pregnancy and their subsequent annual incidence rate of NIDDM was 30.9% (95% CI 12.7-49.1), more than 2.5 times the annual incidence rate of NIDDM in the cohort overall (11.9%; 95% CI 10.0-13.8). Proportional hazards regression analysis using the presence or absence of an additional pregnancy as a time-dependent variable confirmed that an additional pregnancy increased the rate ratio of NIDDM to 3.34 (95% CI 1.80-6.19), compared with women without an additional pregnancy after adjustment for other potential diabetes risk factors during the index pregnancy (antepartum oral glucose tolerance, highest fasting glucose, gestational age at diagnosis of gestational diabetes) and during follow-up (postpartum body mass index [BMI], and glucose tolerance, weight change, breast feeding, and months of contraceptive use). Weight gain also was independently associated with an increased risk of NIDDM; the rate ratio was 1.95 (95% CI 1.63-2.33) for each 10 lb (4.5 kg) gained during follow-up after adjustment for the additional pregnancy and the other potential risk factors.
The study showed that a single pregnancy, independent of the well-known effect of weight gain, accelerated the development of NIDDM in a group of women with a high prevalence of pancreatic beta-cell dysfunction. This finding implies that episodes of insulin resistance may contribute to the decline in beta-cell function that leads to NIDDM in many high-risk individuals.
妊娠与显著的胰岛素抵抗相关,而在一般人群中,这种胰岛素抵抗似乎对非胰岛素依赖型糖尿病(NIDDM)的长期风险影响甚微(若有影响的话)。本研究的目的是检验妊娠是否会改变胰腺β细胞功能障碍患病率较高的女性患NIDDM的风险,妊娠糖尿病史可表明胰腺β细胞功能障碍患病率较高。
该队列由666名患有妊娠糖尿病的拉丁裔女性组成,她们在一家高危计划生育诊所就诊。对她们进行了长达7.5年的随访,在此期间,每年对她们进行称重并进行口服葡萄糖耐量试验。研究了再次妊娠以及其他糖尿病风险因素的影响。
87名(13%)女性再次怀孕。其中80名女性在再次怀孕后并未立即患NIDDM,其随后NIDDM的年发病率为30.9%(95%可信区间12.7 - 49.1),是该队列总体NIDDM年发病率(11.9%;95%可信区间10.0 - 13.8)的2.5倍多。使用是否再次怀孕作为时间依赖性变量的比例风险回归分析证实,在对首次妊娠期间(产前口服葡萄糖耐量、最高空腹血糖、妊娠糖尿病诊断时的孕周)和随访期间(产后体重指数[BMI]、葡萄糖耐量、体重变化、母乳喂养及使用避孕药的月数)的其他潜在糖尿病风险因素进行调整后,与未再次怀孕的女性相比,再次怀孕使NIDDM的发病率比值增至3.34(95%可信区间1.80 - 6.19)。体重增加也与NIDDM风险增加独立相关;在对再次怀孕及其他潜在风险因素进行调整后,随访期间每增加10磅(4.5千克)体重,发病率比值为1.95(95%可信区间1.63 - 2.33)。
该研究表明,单次妊娠独立于众所周知的体重增加效应,加速了胰腺β细胞功能障碍患病率较高的一组女性NIDDM的发展。这一发现意味着胰岛素抵抗发作可能导致许多高危个体中导致NIDDM的β细胞功能下降。